We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Magnetic Particle Processing Attracts Influenza Researchers

By LabMedica International staff writers
Posted on 07 Nov 2011
A German life sciences research laboratory has acquired an advanced magnetic particle processor to enhance its efforts to study the molecular genetics of the H1N1 influenza virus that was responsible for last year’s flu pandemic.

The University of Applied Sciences (Bielefeld, Germany) will now be employing a new Thermo Fisher Scientific Inc. More...
(Milford, MA, USA) KingFisher Flex magnetic particle processor. The instrument’s patented magnetic separation technology is expected to streamline high-throughput data collection.

The KingFisher Flex has been described as a truly flexible solution for genomics studies with a 24-rod magnetic head in combination with a 24-well deep plate. This format allows users to achieve processing volumes up to five mL. Alternatively, for higher throughput requirements, 96 samples can be processed from 20 mL-1,000 mL total volume using a 96-rod magnetic head and 96-well deep or shallow plates.

The KingFisher is an open and flexible system that lets the operator use any magnetic particle based kit to meet the application demands while its easy-to-use BindIt Software package provides instrument control, protocol creation, and modification capabilities.

“As viral strains increasingly mutate, they become harder for the adaptive immune system to fight, and, therefore, they pose a significant health threat to the general public,” said Dr. Carsten Tiemann, project director at the University of Applied Sciences. “In our work within infectious diseases, specifically H1N1 screening, we found the KingFisher Flex to be extremely fast and reliable for nucleic acid extraction for subsequent downstream analysis.”

Related Links:
University of Applied Sciences
Thermo Fisher Scientific Inc.


Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Calprotectin Assay
Fecal Calprotectin ELISA
New
Cytomegalovirus Test
NovaLisa Cytomegalovirus (CMV) IgG Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.